Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
30 studies found for:    teriflunomide
Show Display Options
RSS Create an RSS feed from your search for:
teriflunomide
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride
Conditions: Teriflunomide Elimination;   Healthy Volunteers
Interventions: Drug: teriflunomide;   Drug: Colestipol
2 Completed
Has Results
Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Glatiramer Acetate (GA)
3 Completed
Has Results
Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for Teriflunomide);   Drug: Interferon-β
4 Completed Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients
Condition: Multiple Sclerosis
Intervention: Drug: TERIFLUNOMIDE HMR1726
5 Recruiting Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
Condition: Multiple Sclerosis
Intervention: Drug: teriflunomide
6 Completed
Has Results
Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide)
7 Completed Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With Relapses
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (placebo for teriflunomide)
8 Completed
Has Results
Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo
9 Completed
Has Results
Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Interferon-β [IFN-β];   Drug: Glatiramer Acetate [GA]
10 Not yet recruiting Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis
Condition: Relapsing Multiple Sclerosis
Interventions: Drug: Ofatumumab subcutaneous injection;   Drug: Placebo orally matching to teriflunomide;   Drug: Teriflunomide orally;   Drug: Placebo subcutanous injection matching to ofatumumab
11 Recruiting Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.
Condition: Relapsing Multiple Scelrosis
Interventions: Drug: Ofatumumab subcutaneous injection;   Drug: Placebo orally matching to teriflunomide;   Drug: Teriflunomide orally;   Drug: Placebo subcutaneous injection matching to ofatumumab
12 Terminated
Has Results
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta
Condition: Multiple Sclerosis Relapse
Interventions: Drug: Teriflunomide;   Drug: Placebo (for teriflunomide);   Drug: Interferon-beta (IFN-beta)
13 Completed
Has Results
An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: Teriflunomide
14 Completed
Has Results
Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide
Condition: Multiple Sclerosis
Interventions: Drug: teriflunomide;   Drug: Interferon-β-1;   Biological: Influenza vaccine
15 Completed
Has Results
A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Interferon β-1a;   Drug: Teriflunomide
16 Enrolling by invitation Teriflunomide Observational Effectiveness Study
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Teriflunomide
17 Completed A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide HMR1726;   Drug: cholestyramine
18 Completed Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: teriflunomide HMR1726;   Drug: cholestyramine;   Drug: charcoal
19 Completed Th Effects of Aubagio on Brain Pathology in Multiple Sclerosis Studied Over 12 Months
Condition: Multiple Sclerosis
Intervention: Other: MRI
20 Recruiting Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Teriflunomide HMR1726;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results    Last Page
Indicates status has not been verified in more than two years